consumer genomics 23andMe Fiscal Q2 Revenues Grow 37 Percent as Firm Leans Into DTC Primary Care Strategy Telehealth services from the 2021 acquisition of Lemonaid Health fueled much of the growth for 23andMe in the quarter ended Sept. 30. Saudi Investment Fund Dammam Valley Takes Majority Stake in Arcensus The investment fund of Imam Abdulrahman bin Faisal University promised to maintain the "autonomy" of German DTC clinical genetic testing startup Arcensus. 23andMe Pins Future on 'Genomic Health Service,' Therapeutic Development Premium The company reported a 9 percent increase in revenues in FY2023 Q1, despite a higher net loss, as it continues to integrate Lemonaid Health. Nucleus Genomics Acquires Polygenic Risk Score Tool The New York-based direct-to-consumer startup said it will integrate the Impute.me technology into its in-development genetic analysis platform. Startup Nucleus Genomics Raises $14M to Roll Out Consumer Polygenic Risk Platform Premium The direct-to-consumer data analysis company faces a tough challenge to realize its mission of becoming a hub for WGS-informed healthcare decision-making. May 27, 2022 23andMe Counting on Lemonaid Health to Achieve Vision of Personalized Care Premium May 3, 2022 LetsGetChecked Completes Acquisition of BioIQ Feb 22, 2022 Arcensus Hopes DTC Testing Will Help Genome Sequencing Become First-Line Rare Disease Diagnostic Premium Feb 18, 2022 InsideTracker Boosts Scientific Credentials for Genome-Driven Lifestyle Platform Premium Jan 10, 2022 23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test Jan 7, 2022 International Team Debuts New Platform for DIY Genetic Analysis and Interpretation Premium Dec 3, 2021 SelfDecode Moves Into B2B Services as it Seeks to Diversify, Increase its Reach Premium Nov 10, 2021 23andMe Fiscal Q2 Revenues Increase 7 Percent Oct 25, 2021 23andMe Gains Foothold in Primary Care, Disease Prevention With Lemonaid Health Acquisition Premium Sep 21, 2021 Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test Sep 8, 2021 Recuro Health Acquires 'Health Intelligence' Firm MyLifeIQ Apr 22, 2021 Seqster Closes $12M Series A Funding Round Mar 1, 2021 Seqster, Medable Team on Data Integration for Clinical Trials Feb 26, 2021 GenomSys Banks on MPEG-G Standard to Make Genome Analysis Mobile Premium Jan 21, 2021 Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics Premium Jan 15, 2021 Ancestry to Discontinue NGS-Based AncestryHealth Service Dec 10, 2020 Following Acquisition, UK Firm MyHealthChecked Launches SARS-CoV-2 Consumer Testing Service Premium Nov 23, 2020 Prototype GenoShare Tool Aims to Help Patients Understand Risks of Genomic Data Sharing Premium Oct 26, 2020 GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking Sep 21, 2020 Nebula Genomics, Oasis Labs Partner to Offer Secure Personal Genomic Data Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.